|
[Related PubMed/MEDLINE]
Total Number of Papers: 596
|
|
|
|
|
[Display Entries]
|
|
|
| |
|
[Entries Per Page]
|
|
per page
|
| |
|
Page Control
|
|
|
|
Page: of
|
|
|
|
| Abbreviation |
: MSKCC |
| Long Form |
: Memorial Sloan-Kettering Cancer Center |
|
| No. |
Year |
Title |
Co-occurring Abbreviation |
| 1 |
2023 |
Demographics, Pattern of Care & Outcomes of Primary CNS Lymphoma- Experience from a Tertiary Care Cancer Center in India. |
ACST, ECOG, HD-MTX, IELSG, OS, PCNSL, PFS, PS, WBRT |
| 2 |
2023 |
Real-life experience of patients with sarcomatoid renal cell carcinoma: a multicenter retrospective study. |
OS, RCC, SRCC, TKI |
| 3 |
2023 |
Representativeness of initial skin biopsies showing pure desmoplastic melanoma: implications for management. |
DM, MDM, MIA, PDM, SLNB |
| 4 |
2022 |
"Long-term outcome in endometrial cancer patients after robot-assisted laparoscopic surgery with sentinel lymph node mapping". |
SLN |
| 5 |
2022 |
A New Model for Predicting Nonsentinel Lymph Node Metastasis in Early-Stage Breast Cancer Using MMP15. |
ALND, BC, MMP15, NSLN, ROC, SLNs |
| 6 |
2022 |
A Novel Microbiome Signature in Gastric Cancer: A Two Independent Cohort Retrospective Analysis. |
GC |
| 7 |
2022 |
Association of High Tumor Mutation Burden in Non-Small Cell Lung Cancers With Increased Immune Infiltration and Improved Clinical Outcomes of PD-L1 Blockade Across PD-L1 Expression Levels. |
DFCI, NSCLC, ORR, OS, PD-1, PD-L1, PFS, TMB |
| 8 |
2022 |
Attention-based Deep Learning for the Preoperative Differentiation of Axillary Lymph Node Metastasis in Breast Cancer on DCE-MRI. |
ALN, AUC, DCE-MRI, DL, ResNet |
| 9 |
2022 |
CCND1 Amplification Profiling Identifies a Subtype of Melanoma Associated With Poor Survival and an Immunosuppressive Tumor Microenvironment. |
GSEA, ICIs, TMB |
| 10 |
2022 |
Clinicopathological characteristics and prognosis of metastatic collecting duct carcinoma. |
CDC, IMDC |
| 11 |
2022 |
Clinicopathological characteristics, survival outcomes, and genetic alterations of younger patients with gastric cancer: Results from the China National Cancer Center and cBioPortal datasets. |
GC, NCCGCDB, OS |
| 12 |
2022 |
Comprehensive Analysis of Cell Cycle-Related Genes in Patients With Prostate Cancer. |
CCRGs, GSVA, HPA, KM, RFS |
| 13 |
2022 |
Contemporary seminal vesicle invasion rates in NCCN high-risk prostate cancer patients. |
DCAs, NCCN, PCa, PSA, SEER, SVI |
| 14 |
2022 |
Correlations of switch/sucrose nonfermentable complex mutations with clinical outcomes in advanced non-small cell lung cancer. |
CI, EGFR-mutant, EGFR-TKIs, HR, ICIs, KRAS, NSCLC, PFS |
| 15 |
2022 |
Diagnostic Accuracy of Contemporary Selection Criteria in Prostate Cancer Patients Eligible for Active Surveillance: A Bayesian Network Meta-Analysis. |
AS, DOR, EC, NMA, PRIAS, UCSF, UM, UT |
| 16 |
2022 |
Effect of Preoperative Treatment on the Performance of Predictive Nomograms in Primary Retroperitoneal Sarcoma. |
DFS, DR, DSD, LR, OS, RPS |
| 17 |
2022 |
External validation of the MSKCC nomogram to estimate five-year overall survival after surgery for stage I-III colon cancer in a Dutch population. |
NCR, OS |
| 18 |
2022 |
Family as a Bridge to Improve Meaning in Latinx Individuals Coping with Cancer. |
LMC, PHSU |
| 19 |
2022 |
First person profile: Monica Morrow, MD: The chief of the Breast Service at Memorial Sloan Kettering Cancer Center (MSKCC) has made a lasting impact on breast surgical oncology: The chief of the Breast Service at Memorial Sloan Kettering Cancer Center (MSKCC) has made a lasting impact on breast surgical oncology. |
--- |
| 20 |
2022 |
First-Line Lenvatinib Plus Pembrolizumab or Everolimus versus Sunitinib for Advanced Renal Cell Carcinoma: A United States-Based Cost-Effectiveness Analysis. |
aRCC, ICERs, IMDC, LP, LYs, QALYs, US |
| 21 |
2022 |
Genomic and clinicopathological features of lung adenocarcinomas with micropapillary component. |
LA |
| 22 |
2022 |
Genomic Features of Solid Tumor Patients Harboring ALK/ROS1/NTRK Gene Fusions. |
ALK, CNVs, NGS, NTRK, PD-L1, ROS1, RTK |
| 23 |
2022 |
High tumor mutation burden indicates better prognosis in colorectal cancer patients with KRAS mutations. |
CRC, OS, TMB |
| 24 |
2022 |
Identification and validation of a genomic mutation signature as a predictor for immunotherapy in NSCLC. |
GMS, ICI, NSCLC, OS, PFS |
| 25 |
2022 |
Identification and validation of an E2F-related gene signature for predicting recurrence-free survival in human prostate cancer. |
GSVA, PCa, RFS, ROC, TCGA-PRAD |
| 26 |
2022 |
Identification ofISG15 and ZFP36 as novel hypoxia- and immune-related gene signatures contributing to a new perspective for the treatment of prostate cancer by bioinformatics and experimental verification. |
PCa, WB |
| 27 |
2022 |
Incidence of brain metastases in patients with early HER2-positive breast cancer receiving neoadjuvant chemotherapy with trastuzumab and pertuzumab. |
BM, DFS, NAC, OS, pCR |
| 28 |
2022 |
Integrative genomic and transcriptomic analyses illuminate the ontology of HER2-low breast carcinomas. |
BCs, HLBCs |
| 29 |
2022 |
Integrin Expression in Localized Prostate Cancer: A TCGA and MSKCC Cohort-based Exploratory In Silico Analysis. |
AJCC, DFS, ISUP, ITG, PC |
| 30 |
2022 |
Intratumoral and peritumoral radiomics for preoperatively predicting the axillary non-sentinel lymph node metastasis in breast cancer on the basis of contrast-enhanced mammography: a multicenter study. |
AUC, CEM, CI, NSLN, ROIs |
| 31 |
2022 |
Lack of complete response pretransplant is not associated with inferior overall survival for stage 4a metastatic retinoblastoma. |
CR, IFRT, OS, PR, Rb, VGPR |
| 32 |
2022 |
Machine Learning-Based Epigenetic Classifiers for Axillary Staging of Patients with ER-Positive Early-Stage Breast Cancer. |
AUC, DMS, DNAm, EBC, ER, MDACC |
| 33 |
2022 |
MED12 mutation as a potential predictive biomarker for immune checkpoint inhibitors in pan-cancer. |
DDR, ICIs, MED12, MED12-Mut, MED12-Wt, WES |
| 34 |
2022 |
Molecular Subtypes of Head and Neck Cancer in Patients of African Ancestry. |
--- |
| 35 |
2022 |
mTOR pathway gene mutations predict response to immune checkpoint inhibitors in multiple cancers. |
ICI, TMB |
| 36 |
2022 |
Mutation patterns and evolutionary action score of TP53 enable identification of a patient population with poor prognosis in advanced non-small cell lung cancer. |
DDR, EAp53, NSCLC, OS |
| 37 |
2022 |
Non‑small cell lung cancer carrying PBRM1 mutation suggests an immunologically cold phenotype leading to immunotherapy failure even with high TMB. |
MT, NSCLC, OS, PFS, WT |
| 38 |
2022 |
Predictive Value of Cribriform and Intraductal Carcinoma for the Nomogram-based Selection of Prostate Cancer Patients for Pelvic Lymph Node Dissection. |
AUC, LNM, PCa |
| 39 |
2022 |
Preoperative prediction of pelvic lymph nodes metastasis in prostate cancer using an ADC-based radiomics model: comparison with clinical nomograms and PI-RADS assessment. |
AUC, DCA, ePLND, PCa, PLNM, RP |
| 40 |
2022 |
Preoperative predictive factors affecting sentinel lymph node positivity in breast cancer and comparison of their effectiveness with existing nomograms. |
ESBC, HER2, LVI, MDACC, ROC, SLN |
| 41 |
2022 |
Proposed new prognostic model using the systemic immune-inflammation index for primary central nervous system lymphoma: A prospective-retrospective multicohort analysis. |
OS, PCNSL, PFS, SII |
| 42 |
2022 |
The long-term evolution of melanocytic nevi among high-risk adults. |
TBP |
| 43 |
2022 |
Time to initiation of pre-emptive therapy for cytomegalovirus impacts overall survival in pediatric hematopoietic stem cell transplant recipients. |
CI, CMV, HSCT, OS, TCD |
| 44 |
2022 |
[Establishment of a mutation prediction model for evaluating the efficacy of immunotherapy in renal carcinoma]. |
ICI, TMB |
| 45 |
2021 |
A Comparison of Predicted Ipsilateral Tumor Recurrence Risks in Patients With Ductal Carcinoma in Situ of the Breast After Breast-Conserving Surgery by Breast Radiation Oncologists, the Van Nuys Prognostic Index, the Memorial Sloan Kettering Cancer Center DCIS Nomogram, and the 12-Gene DCIS Score Assay. |
DCIS, IBE |
| 46 |
2021 |
A Novel Prognostic Marker for Primary CNS Lymphoma: Lactate Dehydrogenase-to-Lymphocyte Ratio Improves Stratification of Patients Within the Low and Intermediate MSKCC Risk Groups. |
dNLR, ECOG PS, NHL, NLR, OS, PCNSL, ROC |
| 47 |
2021 |
Aesthetic forehead reduction in female patients: Surgical details and analysis of outcome. |
--- |
| 48 |
2021 |
An independent assessment of an artificial intelligence system for prostate cancer detection shows strong diagnostic accuracy. |
WSIs |
| 49 |
2021 |
Analysis of the EGFR Amplification and CDKN2A Deletion Regulated Transcriptomic Signatures Reveals the Prognostic Significance of SPATS2L in Patients With Glioma. |
CGGA, EGFR, GBM, LGG, SPATS2L |
| 50 |
2021 |
Application of a novel machine learning framework for predicting non-metastatic prostate cancer-specific mortality in men using the Surveillance, Epidemiology, and End Results (SEER) database. |
C-index, SEER |
| 51 |
2021 |
Arsenic trioxide therapy predisposes to herpes zoster reactivation despite minimally myelosuppressive therapy. |
APL, ATO, ATRA |
| 52 |
2021 |
Association of MUC19 Mutation With Clinical Benefits of Anti-PD-1 Inhibitors in Non-small Cell Lung Cancer. |
DCB, ECOG, NSCLC, PFS, TME, WES |
| 53 |
2021 |
Cardiac radiation-induced sarcomas: A SEER population-based study and a literature review. |
RIS, SEER |
| 54 |
2021 |
CDKN2A Alterations and Response to Immunotherapy in Solid Tumors. |
DFCI, GA, ICI |
| 55 |
2021 |
Circulating Tumor Cell Chromosomal Instability and Neuroendocrine Phenotype by Immunomorphology and Poor Outcomes in Men with mCRPC Treated with Abiraterone or Enzalutamide. |
CI, CIN, CTC, mCRPC, NE, OS, PH |
| 56 |
2021 |
Complete Blood Count Score Model Predicts Inferior Prognosis in Primary Central Nervous System Lymphoma. |
CBCs, HR, NLR, OS, PCNSL, PFS, PLR, SII, SIRI |
| 57 |
2021 |
Development of a Novel Risk Score to Select the Optimal Candidate for Cytoreductive Nephrectomy Among Patients with Metastatic Renal Cell Carcinoma. Results from a Multi-institutional Registry (REMARCC). |
C-index, CN, IMDC, mRCC, OM, REMARCC |
| 58 |
2021 |
Differential Expression of a Panel of Ten CNTN1-Associated Genes during Prostate Cancer Progression and the Predictive Properties of the Panel Towards Prostate Cancer Relapse. |
CI, CNTN1, CRPC, HR, LE, PC |
| 59 |
2021 |
Discharge prescribing of enteral opioids in opioid naive patients following non-surgical intensive care: A retrospective cohort study. |
EMR, LOS |
| 60 |
2021 |
Driver gene alterations profiling of Chinese non-small cell lung cancer and the effects of co-occurring alterations on immunotherapy. |
EGFR, NSCLC |
| 61 |
2021 |
EPHA7 mutation as a predictive biomarker for immune checkpoint inhibitors in multiple cancers. |
CNA, EPHA7-MUT, EPHA7-WT, ICIs, TMB, WES |
| 62 |
2021 |
External Validation and Addition of Prostate-specific Membrane Antigen Positron Emission Tomography to the Most Frequently Used Nomograms for the Prediction of Pelvic Lymph-node Metastases: an International Multicenter Study. |
AUC, ePLND, PCa, PET, PSMA, RARP |
| 63 |
2021 |
External validation of the Memorial Sloan Kettering Cancer Centre and Briganti nomograms for the prediction of lymph node involvement of prostate cancer using clinical stage assessed by magnetic resonance imaging. |
AUC, CI, DRE, ePLND, LNI, mpMRI, T stage |
| 64 |
2021 |
Fifteen-MiRNA-Based Signature Is a Reliable Prognosis-Predicting Tool for Prostate Cancer Patients. |
RFS |
| 65 |
2021 |
Gene Mutation Classification through Text Evidence Facilitating Cancer Tumour Detection. |
LR, NLP, RF, RNN, XGB |
| 66 |
2021 |
Genetic Profiles of Aggressive Variants of Papillary Thyroid Carcinomas. |
ATCs, PDTCs, PTC |
| 67 |
2021 |
Head-to-Head Comparison of Two Nomograms Predicting Probability of Lymph Node Invasion in Prostate Cancer and the Therapeutic Impact of Higher Nomogram Threshold. |
AUC, DCA, LNI, PCa, PLND, RP |
| 68 |
2021 |
Influence of Different Age Cutoff Points on the Prediction of Prognosis of Cancer Patients Receiving ICIs and Potential Mechanistic Exploration. |
DDR, HR, ICIs, NAL, OS, TMB |
| 69 |
2021 |
Integration of clinicopathologic identification and deep transferrable image feature representation improves predictions of lymph node metastasis in prostate cancer. |
AUCs, ePLND, PCa, PLNM |
| 70 |
2021 |
Mutations in DNA damage response pathways as a potential biomarker for immune checkpoint blockade efficacy: evidence from a seven-cancer immunotherapy cohort. |
DDR, ICB |
| 71 |
2021 |
Naxitamab: a humanized anti-glycolipid disialoganglioside (anti-GD2) monoclonal antibody for treatment of neuroblastoma. |
FDA, GM-CSF, HR-NBL |
| 72 |
2021 |
Outcomes of Patients with COVID-19 from a Specialized Cancer Care Emergency Room. |
AUC, ED, LOSETD, UCC |
| 73 |
2021 |
Pathology Informatics Education during the COVID-19 Pandemic at Memorial Sloan Kettering Cancer Center (MSKCC). |
--- |
| 74 |
2021 |
Predicting survival in colorectal carcinoma after curative resection: a new prognostic nomogram. |
AUC, C-index, CRC, MMRd, ROC |
| 75 |
2021 |
Prediction of R0/R+ surgery by different classifications for locally recurrent rectal cancer. |
LRRC, NCIM |
| 76 |
2021 |
Predictive Value of the TP53/PIK3CA/ATM Mutation Classifier for Patients With Bladder Cancer Responding to Immune Checkpoint Inhibitor Therapy. |
ICI |
| 77 |
2021 |
Preoperative ultrasound-based radiomics score can improve the accuracy of the Memorial Sloan Kettering Cancer Center nomogram for predicting sentinel lymph node metastasis in breast cancer. |
AUC, DCA, LASSO, mRMR, ROC, ROIs, SLN, US |
| 78 |
2021 |
Prognosis and Genomic Landscape of Liver Metastasis in Patients With Breast Cancer. |
BCLM, DFS, KPS, LM, OS, PBC, PFS, SCHI |
| 79 |
2021 |
Prognosis of Japanese metastatic renal cell carcinoma patients in the targeted therapy era. |
IMDC, JMRC |
| 80 |
2021 |
Prognostic factors for overall survival in patients with clear cell metastatic renal cell carcinoma: Model development and external validation with Memorial Sloan Kettering Cancer Center model and the international metastatic renal cell carcinoma database consortium model. |
AIC, IMDC, KRoCS, mRCC |
| 81 |
2021 |
Prognostic Role of Blood Markers in Primary Central Nervous System Lymphoma Patients Treated With High-Dose Methotrexate-Based Therapy. |
Hb, HD-MTX, LMR, NLR, OS, PCNSL, PFS, SII, TBIL |
| 82 |
2021 |
Prognostic value of programmed death-ligand 1 status in Japanese patients with renal cell carcinoma. |
IC, OS, PD-L1, PSW, RCC |
| 83 |
2021 |
Prostate Magnetic Resonance Imaging Analyses, Clinical Parameters, and Preoperative Nomograms in the Prediction of Extraprostatic Extension. |
AUC, EPE, mpMRI, OR, PCa, RP |
| 84 |
2021 |
Randomized Trial of Two Induction Therapy Regimens for High-Risk Neuroblastoma: HR-NBL1.5 International Society of Pediatric Oncology European Neuroblastoma Group Study. |
EFS, mCR |
| 85 |
2021 |
Real-life drug-drug and herb-drug interactions in outpatients taking oral anticancer drugs: comparison with databases. |
CAM, DDI, HDI |
| 86 |
2021 |
Real-world outcomes in patients with metastatic renal cell carcinoma according to risk factors: the STAR-TOR registry. |
IMDC |
| 87 |
2021 |
Risks and benefits of reinduction ipilimumab/nivolumab in melanoma patients previously treated with ipilimumab/nivolumab. |
BORs, irAEs, OS, TTF |
| 88 |
2021 |
The Cost of Enfortumab Vedotin Wastage Due to Vial Size-A Real-World Analysis. |
EV |
| 89 |
2021 |
The Effect of Anastomotic Leakage on the Incidence and Severity of Low Anterior Resection Syndrome in Patients Undergoing Proctectomy: A Propensity Score Matching Analysis. |
AL, LARS |
| 90 |
2021 |
The Effect of Smoking on the Immune Microenvironment and Immunogenicity and Its Relationship With the Prognosis of Immune Checkpoint Inhibitors in Non-small Cell Lung Cancer. |
GEO, HR, ICIs, NSCLC |
| 91 |
2021 |
The Relationship Between Food Consumption and Bowel Symptoms Among Patients With Rectal Cancer After Sphincter-Saving Surgery. |
--- |
| 92 |
2021 |
Treatment of Ductal Carcinoma in Situ: Considerations for Tailoring Therapy in the Contemporary Era. |
BCS, DCIS, LR |
| 93 |
2021 |
[Impact of surgical treatment for locally recurrent rectal cancer on the quality of life of patients]. |
FSFI, IIEF-5, IPSS, LRRC, SF-36 |
| 94 |
2020 |
A new prognostic score for disease progression and mortality in patients with newly diagnosed primary CNS lymphoma. |
IELSG, NB, OS, PCNSL, PFS |
| 95 |
2020 |
A novel miRNA inhibits metastasis of prostate cancer via decreasing CREBBP-mediated histone acetylation. |
--- |
| 96 |
2020 |
Age and Mutations as Predictors of the Response to Immunotherapy in Head and Neck Squamous Cell Cancer. |
HNSC, ICIs, MSI, MT, OS, TMB, WT |
| 97 |
2020 |
Age, sex, and specific gene mutations affect the effects of immune checkpoint inhibitors in colorectal cancer. |
CRC, ICIs, MT, OS |
| 98 |
2020 |
Bevacizumab does not increase risk of perforation in patients undergoing percutaneous endoscopic gastrostomy or jejunostomy placement. |
GI, PEG, PEJ |
| 99 |
2020 |
CCND1 Amplification Contributes to Immunosuppression and Is Associated With a Poor Prognosis to Immune Checkpoint Inhibitors in Solid Tumors. |
CCND1, DCs, ICIs, mTOR, PI3K, TGF, TME |
| 100 |
2020 |
Characterizations of Cancer Gene Mutations in Chinese Metastatic Breast Cancer Patients. |
BC, CNAs, maxAF, PCAWG, TNBC |
|
A Search Service for Abbreviation / Long Form
